Page last updated: 2024-11-12

grayanotoxin iii

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

grayanotoxin III: from leaves of Leucothoe grayana (Ericaceae); RN refers to (3beta,6beta,14R)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Leucothoegenus[no description available]EricaceaeThe heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH]
Leucothoe grayanaspecies[no description available]EricaceaeThe heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.[MeSH]

Cross-References

ID SourceID
PubMed CID11057730
CHEMBL ID454313
SCHEMBL ID1008212
MeSH IDM0074824

Synonyms (25)

Synonym
gtpl2628
(3beta,6beta,14r)-grayanotoxane-3,5,6,10,14,16-hexol
brn 2059374
deacetylandromedotoxin
grayanotoxane-3,5,6,10,14,16-hexol, (3-beta,6-beta,14r)-
7,9a-methano-9ah-cyclopenta(b)heptalene-2,4,8,11,11a,12(1h)-hexol, dodecahydro-1,1,4,8-tetramethyl-, (2s,3as,4r,4ar,7r,8r,9as,11r,11ar,12r)-
grayanotoxane-3,5,6,10,14,16-hexol, (3beta,6beta,14r)-
nsc 323778
andromedol
deacylasebotoxin i
nsc-323778
4678-45-9
grayanotoxin iii
CHEMBL454313
grayanotoxin-iii
unii-zkr09nt58c
zkr09nt58c ,
SCHEMBL1008212
grayanotoxane-3,5,6,10,14,16-hexol, (3.beta.,6.beta.,14r)-
(-)-grayanotoxin iii
grayanotoxin iii [mi]
fda-1962
grayanotoxin iii (andromedol)
Q27077854
DTXSID60878540

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Grayanotoxin (GTX) III, a tetracyclic diterpenoid, is the main toxic component obtained from the leaves of Leucothoe grayana MAX."( Transformation of grayanotoxin III to 10-epi-grayanotoxin III. Its X-ray crystallographic analysis and acute toxicity in mice.
Katakawa, J; Matuura, T; Narama, I; Sato, M; Terai, T; Tetsumi, M, 1996
)
0.63

Dosage Studied

ExcerptRelevanceReference
" Dosage level of acute toxicity of 10-epi-GTX-III in mice was estimated at about half of natural GTX-III."( Transformation of grayanotoxin III to 10-epi-grayanotoxin III. Its X-ray crystallographic analysis and acute toxicity in mice.
Katakawa, J; Matuura, T; Narama, I; Sato, M; Terai, T; Tetsumi, M, 1996
)
0.63
" In the immunohistochemistry sense, while the BNP level in the AGTX-III groups did not vary significantly, an increase in dosage significantly increased the IL-6, IL-1β, and TNF-α levels in comparison to the control groups."( The cardiotoxic effects of acute and chronic grayanotoxin-III in rats.
Doǧanyiǧit, Z; Kaymak, E; Silici, S, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID324366Induction of light chain 3-GFP level in human H4 cells at 6.0 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324581Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 8 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324584Increase in long-lived protein degradation in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID324418Increase in light chain 3-GFP+ autophagosome vesicle number per cell in human H4 cells at 6.0 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324583Increase in long-lived protein degradation in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324579Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 2 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324470Increase in light chain 3-GFP+ autophagosome vesicle area per cell in human H4 cells at 6.0 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1276155Antinociceptive activity in Kunming mouse model of acute pain assessed as inhibition of acetic acid-induced writhes at 0.08 mg/kg, ip administered 30 mins prior to acetic acid challenge measured for 30 mins relative to control2015Journal of natural products, Dec-24, Volume: 78, Issue:12
Antinociceptive Grayanoids from the Roots of Rhododendron molle.
AID324585Increase in long-lived protein degradation in human H4 cells after 24 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324582Increase in long-lived protein degradation in human H4 cells after 1 hr relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID324522Increase in light chain 3-GFP+ autophagosome vesicle intensity per cell in human H4 cells at 6.0 uM after 24 hrs by high throughput fluorescence microscopy relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID324580Decrease in FYVE-RFP+ vesicle intensity per cell in human H4 cells after 4 hrs relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-27, Volume: 104, Issue:48
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
AID1346781Rat Nav1.4 (Voltage-gated sodium channels)2001Molecular pharmacology, Oct, Volume: 60, Issue:4
Novel site on sodium channel alpha-subunit responsible for the differential sensitivity of grayanotoxin in skeletal and cardiac muscle.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (21.88)18.7374
1990's3 (9.38)18.2507
2000's3 (9.38)29.6817
2010's16 (50.00)24.3611
2020's3 (9.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.73 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (9.09%)4.05%
Observational1 (3.03%)0.25%
Other29 (87.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]